SEC Form 4 · accession 0001209191-17-050342
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay Barth
Officer — Chief Medical Officer
Period of report
Aug 23, 2017
Accepted (ET)
Aug 25, 2017 · 6:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $12.64 | Aug 23, 2017 | A | 3,000 | A | — | Aug 23, 2027 | Common Stock | 3,000 | 3,000 | I |
Explanation of responses
- F1These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on August 23, 2018. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on September 1, 2018, with the final installment vesting on August 1, 2021.